N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.05p
   
  • Change Today:
    -0.050p
  • 52 Week High: 6.30
  • 52 Week Low: 0.43
  • Currency: UK Pounds
  • Shares Issued: 156.08m
  • Volume: 0
  • Market Cap: 9.44m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-20 Interim n/a (0.58) (0.48)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 n/a (0.16) (9.08)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (0.19) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.11 (1.93) (1.26)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.07 (1.39) (1.32)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (0.95) (0.87)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-21 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

N4 Pharma Market Data

Currency UK Pounds
Share Price 6.05p
Change Today -0.050p
% Change -0.82 %
52 Week High 6.30
52 Week Low 0.43
Volume 0
Shares Issued 156.08m
Market Cap 9.44m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.74% below the market average58.74% below the market average58.74% below the market average58.74% below the market average58.74% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Value
58.74% below the market average58.74% below the market average58.74% below the market average58.74% below the market average58.74% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page